Tibulizumab, CAS 1849636-24-3

Product Description: Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Robert J Benschop, et al. Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. MAbs. 2019 Aug/Sep;11(6):1175-1190.

CAS Number: 1849636-24-3

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related;TNF Receptor

• SKU: MEXHY-P99563-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99563-1
• Package Unit: 1mg
• Quantity Unit: STK
• Conjugate: Unconjugated